After an esteemed 25 year career as an investor and serial entrepreneur, Paul brought his expertise to Discovery Parks in 2017. Paul has built several successful companies, including Mitroflow International Inc., Neovasc Inc. and LightIntegra Technology Inc. that currently employ more than 500 people in British Columbia. Paul is well known for his work supporting and mentoring entrepreneurs and future leaders of the tech industry. His passion for giving back is seen in the many board roles he holds, including: Executive Chairman, LightIntegra Technology Inc.; Chairman of the Board, Neovasc Inc.; G7 Fellow, Creative Destruction Labs – CDL West; Board of Directors, Entrepreneurship at UBC; Board of Directors, BCTECH; Advisory Council Member, UBC Engineering, Applied Science; and Industry Advisory Council, UBC Electrical Engineering department. In 2010 Paul was awarded the British Columbia Angel Investor of the year, and in 2011 he received the BC Life Sciences Leadership Award.
Andrew was appointed to his position of Chief Commercial Officer in 2017 after nearly four years as STEMCELL’s Chief Financial Officer and is responsible for corporate development within the company. Prior to joining STEMCELL, Andrew spent approximately seven years at General Electric in Koln, Paris, New York, Florence and London in a number of positions. In 1996 Andrew co-founded Zaber Technologies in Vancouver which produces and sells micro-positioning equipment globally. Andrew is a Director on the Boards of the BC Tech Association and Life Sciences British Columbia and a director on the boards of Vancouver-based companies Light Integra, Precision Nanosystems, and AbCellera. He is also a frequent volunteer and mentor of the BC New Ventures Business Plan Competition. In 2012, Andrew was named to Business in Vancouver’s Forty Under 40 list.
Prior to joining PenderFund in 2017, Maria acquired 16 years of investing experience in emerging growth companies, with a focus in IT-related businesses. She spent 11 years with one of Canada’s largest venture capital firms where she invested in multiple early-stage ventures and served on a variety of boards, mostly in the areas of enterprise software, e-commerce and med-tech. Maria has held operational roles at early-stage companies, serving on boards, facilitating M&A and leading financings. She is currently a Director of GreenSpace Brands Inc., a member of the board of advisors for Reach Social, Inc. and an observer on the board of Microdermics, Inc. As an investor in the rapidly changing world of early-stage technology, Maria invests in exceptional entrepreneurs and teams that excel at identifying business opportunities, develop world-class products and are dedicated to building great companies.
Jerel Davis, Ph.D., is a Managing Director based in Vancouver, Canada. Since joining Versant in 2011, he has been involved in launching and investing in a number of Versant’s portfolio companies including Quanticel, Novira, Crispr, Blueline, Northern, Turnstone, BlueRock, Repare, VenatoRx and several Inception companies. He has led Versant’s execution of creative transactions with multiple pharmaceutical partners including Celgene, Roche and Bayer, and was instrumental in establishing Versant’s presence in Canada, including the creation of our company building infrastructure in Vancouver, Toronto and Montreal. Jerel was promoted to Managing Director at Versant in 2015.
Prior to joining Versant, Jerel was an Associate Principal at McKinsey and Company where he advised healthcare corporations in pharmaceuticals, biotechnology, medical device and molecular diagnostics. He has worked in a number of healthcare markets globally including the U.S., Canada, Europe, China, Russia and India. Jerel was a post-doctoral fellow at Stanford University, where he also completed his Ph.D., and trained at Amgen as a researcher.
Antony is a professor in the UBC Department of Mechanical Engineering and the School of Biomedical Engineering and serves as the Director of the Surgical Technologies Lab at the Centre for Hip Health and Mobility in the Vancouver Coastal Health Research Institute (VCHRI). He is also the Co-Director of ICICS (Institute for Computing, Information and Cognitive Systems), with responsibility for Health Technologies, and Director of the HATCH Incubator at VCHRI, which provides medical device entrepreneurs with design and networking space, prototyping facilities, and mentorship for start-up companies. Antony also developed the unique Engineers in Scrubs training program which teaches graduate biomedical engineers how to develop technologies to address important clinical problems. His own research focuses on computer-assisted orthopaedic surgery, medical robotics, and surgical simulators and skill assessment. In partnership with a surgical collaborator, he co-founded Traumis Surgical Systems, which developed a radiation-free method for distal locking of intramedullary nails.